TABLE 2.
Indication | Number (%) of Patients, All Imaging Studies (n = 1705) | Number (%) of Patients, Final Imaging Study (n = 389) |
---|---|---|
Follow up | 502 (29.4%) | 81 (20.8%) |
Altered mental status | 268 (15.7%) | 71 (18.3%) |
Seizures | 214 (12.6%) | 57 (14.7%) |
Fever/Concern for infection | 201 (11.8%) | 58 (14.9%) |
Shunt evaluation | 185 (10.9%) | 6 (1.5%) |
Abnormal neurologic exam | 151 (8.9%) | 37 (9.5%) |
Headache | 78 (4.6%) | 21 (5.4%) |
Vomiting | 58 (3.4%) | 9 (2.3%) |
Hypertension and/or bradycardia | 41 (2.4%) | 11 (2.8%) |
Trauma | 29 (1.7%) | 9 (2.3%) |
Apnea | 23 (1.3%) | 10 (2.6%) |
Cardiac arrest | 21 (1.2%) | 9 (2.3%) |
Concern for hemorrhage | 20 (1.2%) | 10 (2.6%) |
Abnormal sodium | 10 (0.6%) | 5 (1.3%) |